Michael W. Riggs

3.1k total citations · 1 hit paper
50 papers, 2.0k citations indexed

About

Michael W. Riggs is a scholar working on Parasitology, Infectious Diseases and Animal Science and Zoology. According to data from OpenAlex, Michael W. Riggs has authored 50 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Parasitology, 21 papers in Infectious Diseases and 18 papers in Animal Science and Zoology. Recurrent topics in Michael W. Riggs's work include Parasitic Infections and Diagnostics (39 papers), Coccidia and coccidiosis research (18 papers) and Viral gastroenteritis research and epidemiology (12 papers). Michael W. Riggs is often cited by papers focused on Parasitic Infections and Diagnostics (39 papers), Coccidia and coccidiosis research (18 papers) and Viral gastroenteritis research and epidemiology (12 papers). Michael W. Riggs collaborates with scholars based in United States, United Kingdom and Canada. Michael W. Riggs's co-authors include L E Perryman, Deborah A. Schaefer, Rebecca C. Langer, Ronald Fayer, P H Mason, F. Javier Enriquez, Roberta M. O’Connor, Michael J. Arrowood, Lance E. Perryman and Hans Clevers and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Clinical Microbiology.

In The Last Decade

Michael W. Riggs

50 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modelling Cryptosporidium infection in human small intestinal and lung organoids

2018 292 citations Inha Heo, Devanjali Dutta et al. Nature Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael W. Riggs United States	27	1.4k	908	371	283	281	50	2.0k
Mark C. Healey United States	22	867 0.6×	516 0.6×	288 0.8×	146 0.5×	178 0.6×	58	1.2k
Nathalie Ruvoën‐Clouet France	27	228 0.2×	1.9k 2.1×	788 2.1×	334 1.2×	142 0.5×	42	2.7k
Ralf Bialek Germany	29	467 0.3×	1.7k 1.8×	99 0.3×	1.6k 5.5×	401 1.4×	74	2.6k
B Fortier France	21	1.1k 0.8×	342 0.4×	114 0.3×	955 3.4×	38 0.1×	69	2.0k
Diana G. Scorpio United States	21	948 0.7×	872 1.0×	62 0.2×	64 0.2×	57 0.2×	50	1.8k
Susan K. Bliss United States	17	851 0.6×	326 0.4×	34 0.1×	530 1.9×	64 0.2×	20	1.7k
R Hussain Pakistan	31	595 0.4×	1.5k 1.6×	24 0.1×	761 2.7×	136 0.5×	75	2.7k
Marie‐Pierre Brenier‐Pinchart France	30	1.9k 1.4×	480 0.5×	49 0.1×	1.6k 5.5×	61 0.2×	103	2.6k
Martin F. Heyworth United States	18	587 0.4×	385 0.4×	28 0.1×	150 0.5×	27 0.1×	51	1.0k
Antônio Carlos Alessi Brazil	17	276 0.2×	228 0.3×	166 0.4×	293 1.0×	162 0.6×	90	997

Countries citing papers authored by Michael W. Riggs

Since Specialization

Citations

This map shows the geographic impact of Michael W. Riggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Riggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Riggs more than expected).

Fields of papers citing papers by Michael W. Riggs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Riggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Riggs. The network helps show where Michael W. Riggs may publish in the future.

Co-authorship network of co-authors of Michael W. Riggs

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Riggs. A scholar is included among the top collaborators of Michael W. Riggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Riggs. Michael W. Riggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Riggs, Michael W. & Deborah A. Schaefer. (2019). Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics. Methods in molecular biology. 2052. 253–282. 16 indexed citations

Heo, Inha, Devanjali Dutta, Deborah A. Schaefer, et al.. (2018). Modelling Cryptosporidium infection in human small intestinal and lung organoids. Nature Microbiology. 3(7). 814–823. 292 indexed citations breakdown →

Hulverson, Matthew A., Sumiti Vinayak, Ryan Choi, et al.. (2017). Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy. The Journal of Infectious Diseases. 215(8). 1275–1284. 43 indexed citations

Voorhis, Wesley C. Van, J. Stone Doggett, Marilyn Parsons, et al.. (2017). Extended-spectrum antiprotozoal bumped kinase inhibitors: A review. Experimental Parasitology. 180. 71–83. 49 indexed citations

Tatari-Calderone, Zohreh, Heather Gordish‐Dressman, Ross M. Fasano, et al.. (2015). Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease. Human Immunology. 77(1). 35–40. 28 indexed citations

Hricik, Donald E., Peter Nickerson, Richard N. Formica, et al.. (2013). Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury. American Journal of Transplantation. 13(10). 2634–2644. 180 indexed citations

Thivierge, Karine, Sophie Cotton, Deborah A. Schaefer, et al.. (2013). Cathelicidin-like Helminth Defence Molecules (HDMs): Absence of Cytotoxic, Anti-microbial and Anti-protozoan Activities Imply a Specific Adaptation to Immune Modulation. PLoS neglected tropical diseases. 7(7). e2307–e2307. 36 indexed citations

Carryn, Stéphane, Deborah A. Schaefer, Michael Imboden, et al.. (2012). Phospholipases and Cationic Peptides Inhibit Cryptosporidium parvum Sporozoite Infectivity by Parasiticidal and Non-Parasiticidal Mechanisms. Journal of Parasitology. 98(1). 199–204. 29 indexed citations

Priest, Jeffrey W., Angela Mehlert, Michael J. Arrowood, Michael W. Riggs, & Michael A. J. Ferguson. (2003). Characterization of a Low Molecular Weight Glycolipid Antigen from Cryptosporidium parvum. Journal of Biological Chemistry. 278(52). 52212–52222. 21 indexed citations

10.

Wyatt, Carol R., et al.. (2002). ASSOCIATION OF IL-10 EXPRESSION BY MUCOSAL LYMPHOCYTES WITH INCREASED EXPRESSION OF CRYPTOSPORIDIUM PARVUM EPITOPES IN INFECTED EPITHELIUM. Journal of Parasitology. 88(2). 281–286. 8 indexed citations

11.

Riggs, Michael W.. (2002). Recent advances in cryptosporidiosis: the immune response. Microbes and Infection. 4(10). 1067–1080. 101 indexed citations

12.

Riggs, Michael W., et al.. (2001). Targeted Disruption of CSL Ligand ‐ Host Cell Receptor Interaction in Treatment of Cryptosporidium parvum Infection. Journal of Eukaryotic Microbiology. 48(s1). 44S–46S. 1 indexed citations

13.

Langer, Rebecca C., Deborah A. Schaefer, & Michael W. Riggs. (2001). Characterization of an Intestinal Epithelial Cell Receptor Recognized by theCryptosporidium parvumSporozoite Ligand CSL. Infection and Immunity. 69(3). 1661–1670. 26 indexed citations

14.

Riggs, Michael W., Michael McNeil, Lance E. Perryman, et al.. (1999). Cryptosporidium parvumSporozoite Pellicle Antigen Recognized by a Neutralizing Monoclonal Antibody Is a β-Mannosylated Glycolipid. Infection and Immunity. 67(3). 1317–1322. 28 indexed citations

15.

Langer, Rebecca C. & Michael W. Riggs. (1996). Neutralizing Monoclonal Antibody Protects Against Cryptosporidium parvum Infection by Inhibiting Sporozoite Attachment and Invasion. Journal of Eukaryotic Microbiology. 43(5). 76S–77S. 13 indexed citations

16.

Riggs, Michael W., et al.. (1996). Protective Monoclonal Antibodies Define a Distinct, Conserved Epitope on an Apical Complex Exoantigen of Cryptosporidium parvum Sporozoites. Journal of Eukaryotic Microbiology. 43(5). 74S–75S. 3 indexed citations

17.

Prieur, David J., et al.. (1990). Suspected ciliary dysfunction in Chinese Shar Pei pups with pneumonia. American Journal of Veterinary Research. 51(3). 439–446. 11 indexed citations

18.

Riggs, Michael W., et al.. (1990). Cryptosporidium parvum merozoites share neutralization-sensitive epitopes with sporozoites.. The Journal of Immunology. 145(1). 298–304. 52 indexed citations

19.

Riggs, Michael W.. (1987). Evaluation of Foals for Immune Deficiency Disorders. Veterinary Clinics of North America Equine Practice. 3(3). 515–528. 10 indexed citations

20.

Barbee, David D., et al.. (1987). Detection by computed tomography of occult osteochondral defects in the fetlock of a horse. Equine Veterinary Journal. 19(6). 556–558. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact